Cautionary advisory against Ranbaxy drugs, says Apollo PharmacyLeading pharmacy chain Apollo Pharmacy today said it has issued a "cautionary advisory" against drugs made by Ranbaxy Laboratories
07 Jun, 2013, 09.04 PM IST
No plans to change Ranbaxy's name, says Daiichi SankyoRanbaxy’s Japanese parent Daiichi Sankyo has no plans to change the name of the company or delist it from the stock exchange at the moment.
22 May, 2013, 05.00 AM IST
- Ranbaxy, USFDA in settlement talks over $1 billion fine: Report
Settling the issue is of immense importance to Ranbaxy as it is the first firm to file an abbreviated new drug application to launch a gene...
05 May, 2011, 04.04 PM IST
- Merck, Ranbaxy drug development deal called off
US drug maker Merck & Co has terminated its nearly two-year-old alliance with Ranbaxy Laboratories to develop anti-infective medicines, whi...
06 Jan, 2011, 02.44 PM IST
- HC bans MNS Pharma from lipid-control drug sale
Delhi HC has stopped Hyderabad-based MNS Pharmaceuticals from selling its lipid-lowering drug, MHS Rosuv. When contacted, an MSN Pharmaceut...
08 Aug, 2009, 12.46 AM IST
- Aussie regulator puts Ranbaxy under scanner
The Australian drug regulator Therapeutic Goods Administration (TGA) said it is reviewing 62 drugs sold in the country which are made by Ra...
05 Mar, 2009, 12.36 AM IST
- Ranbaxy faces adulteration charges in US
US department of justice has said there was evidence to suggest that Ranbaxy used active pharmaceutical ingredients from unapproved sources...
14 Jul, 2008, 12.34 AM IST
- Ranbaxy faces legal heat from USFDA
The case is related to alleged falsification of records by Ranbaxy that resulted in sale of generic drugs in US which did not meet the stan...
13 Jul, 2008, 03.50 AM IST
- USFDA takes Ranbaxy to court
American health regulator USFDA has filed a motion in a US court seeking 'certain' documents from Ranbaxy, amid reports of systematic fraud...
12 Jul, 2008, 10.48 PM IST
- Ranbaxy inks two deals with group firms
Ranbaxy Laboratories has sold some land and building for Rs 90 crore to a group company, sources said.
22 May, 2008, 12.29 AM IST
- Ranbaxy gets US patent office booster dose in Lipitor case
In what would give a leg up to Ranbaxy, the US Patent and Trademark Office (USPTO) has rejected Pfizer’s appeal to re-issue patent for its ...
29 Apr, 2008, 01.00 AM IST
- Ranbaxy gets US Patent Office booster dose in Lipitor case
India's Ranbaxy Laboratories has received a boost in its patent litigation with Pfizer over cholesterol lowering drug Lipitor (atorvastatin...
28 Apr, 2008, 02.09 PM IST
- WHO agency, Ranbaxy part ways from drug development
WHO agency Medicines for Malaria Venture and Ranbaxy were involved in a four year-long joint development programme for an anti-malarial com...
21 Sep, 2007, 06.50 PM IST
- Ranbaxy to challenge Pfizer’s suit on Caduet
Ranbaxy has said the company will challenge the litigation filed by Pfizer, the world’s largest drug maker.
14 Mar, 2007, 01.00 AM IST
- Ranbaxy stock slides on raids on US offices
The Ranbaxy share price dropped 5% on Thursday in the backdrop of US federal officials conducting a search on the premises of the company’s...
16 Feb, 2007, 03.55 AM IST
- Romania's Damian to head Terapia-Ranbaxy
The template designed by India Inc of managing its global acquisitions with executives handpicked from the local milieu has received one mo...
11 Nov, 2006, 12.00 AM IST
- Ranbaxy to buy 10% in Zenotech for Rs 20 cr
Ranbaxy Laboratories, is close to picking up a 10% stake in Hyderabad-based Zenotech Laboratories for about Rs 20 crore as it moves to plug...
22 Jun, 2006, 12.39 AM IST